BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 30522787)

  • 1. Nonfasting versus fasting lipid profile for cardiovascular risk prediction.
    Langsted A; Nordestgaard BG
    Pathology; 2019 Feb; 51(2):131-141. PubMed ID: 30522787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fasting and nonfasting lipid levels: influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk prediction.
    Langsted A; Freiberg JJ; Nordestgaard BG
    Circulation; 2008 Nov; 118(20):2047-56. PubMed ID: 18955664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points-a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine.
    Nordestgaard BG; Langsted A; Mora S; Kolovou G; Baum H; Bruckert E; Watts GF; Sypniewska G; Wiklund O; Borén J; Chapman MJ; Cobbaert C; Descamps OS; von Eckardstein A; Kamstrup PR; Pulkki K; Kronenberg F; Remaley AT; Rifai N; Ros E; Langlois M;
    Eur Heart J; 2016 Jul; 37(25):1944-58. PubMed ID: 27122601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonfasting hyperlipidemia and cardiovascular disease.
    Nordestgaard BG; Langsted A; Freiberg JJ
    Curr Drug Targets; 2009 Apr; 10(4):328-35. PubMed ID: 19355857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Fasting and nonfasting lipids--secondary publication].
    Langsted A; Freiberg JJ; Nordestgaard BG
    Ugeskr Laeger; 2009 Jun; 171(26):2184-7. PubMed ID: 19678434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Test in Context: Lipid Profile, Fasting Versus Nonfasting.
    Nordestgaard BG
    J Am Coll Cardiol; 2017 Sep; 70(13):1637-1646. PubMed ID: 28935041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fasting Is Not Routinely Required for Determination of a Lipid Profile: Clinical and Laboratory Implications Including Flagging at Desirable Concentration Cutpoints-A Joint Consensus Statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine.
    Nordestgaard BG; Langsted A; Mora S; Kolovou G; Baum H; Bruckert E; Watts GF; Sypniewska G; Wiklund O; Borén J; Chapman MJ; Cobbaert C; Descamps OS; von Eckardstein A; Kamstrup PR; Pulkki K; Kronenberg F; Remaley AT; Rifai N; Ros E; Langlois M;
    Clin Chem; 2016 Jul; 62(7):930-46. PubMed ID: 27235445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonfasting non-high-density lipoprotein cholesterol is adequate for lipid management in hemodialysis patients.
    Desmeules S; Arcand-Bossé JF; Bergeron J; Douville P; Agharazii M
    Am J Kidney Dis; 2005 Jun; 45(6):1067-72. PubMed ID: 15957136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonfasting lipids, lipoproteins, and apolipoproteins in individuals with and without diabetes: 58 434 individuals from the Copenhagen General Population Study.
    Langsted A; Nordestgaard BG
    Clin Chem; 2011 Mar; 57(3):482-9. PubMed ID: 21189274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fasting compared with nonfasting lipids and apolipoproteins for predicting incident cardiovascular events.
    Mora S; Rifai N; Buring JE; Ridker PM
    Circulation; 2008 Sep; 118(10):993-1001. PubMed ID: 18711012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postprandial Hypertriglyceridaemia Revisited in the Era of Non-Fasting Lipid Profile Testing: A 2019 Expert Panel Statement, Main Text.
    Kolovou GD; Watts GF; Mikhailidis DP; Pérez-Martínez P; Mora S; Bilianou H; Panotopoulos G; Katsiki N; Ooi TC; Lopez-Miranda J; Tybjærg-Hansen A; Tentolouris N; Nordestgaard BG
    Curr Vasc Pharmacol; 2019; 17(5):498-514. PubMed ID: 31060488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of fasting and nonfasting serum triglycerides with cardiovascular disease and the role of remnant-like lipoproteins and small dense LDL.
    Stalenhoef AF; de Graaf J
    Curr Opin Lipidol; 2008 Aug; 19(4):355-61. PubMed ID: 18607182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low nonfasting triglycerides and reduced all-cause mortality: a mendelian randomization study.
    Thomsen M; Varbo A; Tybjærg-Hansen A; Nordestgaard BG
    Clin Chem; 2014 May; 60(5):737-46. PubMed ID: 24436475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fasting Versus Nonfasting and Low-Density Lipoprotein Cholesterol Accuracy.
    Sathiyakumar V; Park J; Golozar A; Lazo M; Quispe R; Guallar E; Blumenthal RS; Jones SR; Martin SS
    Circulation; 2018 Jan; 137(1):10-19. PubMed ID: 29038168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between nonfasting and fasting lipid measurements in patients with or without type 2 diabetes mellitus receiving treatment with 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors.
    Weiss R; Harder M; Rowe J
    Clin Ther; 2003 May; 25(5):1490-7. PubMed ID: 12867223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma fasting and nonfasting triglycerides and high-density lipoprotein cholesterol in atherosclerotic stroke: different profiles according to low-density lipoprotein cholesterol.
    Kim SJ; Park YG; Kim JH; Han YK; Cho HK; Bang OY
    Atherosclerosis; 2012 Aug; 223(2):463-7. PubMed ID: 22683121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extreme nonfasting remnant cholesterol vs extreme LDL cholesterol as contributors to cardiovascular disease and all-cause mortality in 90000 individuals from the general population.
    Varbo A; Freiberg JJ; Nordestgaard BG
    Clin Chem; 2015 Mar; 61(3):533-43. PubMed ID: 25605681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women.
    Nordestgaard BG; Benn M; Schnohr P; Tybjaerg-Hansen A
    JAMA; 2007 Jul; 298(3):299-308. PubMed ID: 17635890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accuracy of Non-Fasting Lipid Profile for the Assessment of Lipoprotein Coronary Risk.
    Fatima S; Ijaz A; Sharif TB; Khan DA; Siddique A
    J Coll Physicians Surg Pak; 2016 Dec; 26(12):954-957. PubMed ID: 28043305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Postprandial changes of blood lipid after ordinary Chinese diet and the influencing factors thereof].
    Fu ZF; Liu ML
    Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(4):260-2. PubMed ID: 19552844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.